Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 601 AL 615

Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease

Rowland NC, Kalia SK, Kalia LV, Larson PS, Lim DA, Bankiewicz KS.

Mol Ther Methods Clin Dev. 2016 Jan 13;3:15051. doi: 10.1038/mtm.2015.51. eCollection 2016.

Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients

Antonini A, Fung VS, Boyd JT, Slevin JT, Hall C, Chatamra K, Eaton S, Benesh JA.

Mov Disord. 2016 Apr;31(4):530-7. doi: 10.1002/mds.26528. Epub 2016 Jan 28.

GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up

Odekerken VJ, Boel JA, Schmand BA, de Haan RJ, Figee M, van den Munckhof P, Schuurman PR, de Bie RM; NSTAPS study group.

Neurology. 2016 Feb 23;86(8):755-61. doi: 10.1212/WNL.0000000000002401. Epub 2016 Jan 27.

Comorbidities Matter: A Call to Improve Care for Hospitalized Patients with Alzheimer's and Parkinson's Disease

DiBartolo MC.

J Gerontol Nurs. 2016 Feb;42(2):4-5. doi: 10.3928/00989134-20160113-01.

Specificity and impact of adrenergic projections to the midbrain dopamine system

Mejias-Aponte CA.

Brain Res. 2016 Jun 15;1641(Pt B):258-73. doi: 10.1016/j.brainres.2016.01.036. Epub 2016 Jan 26.

Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis

Khan AA, Quinn TJ, Hewitt J, Fan Y, Dawson J.

Age (Dordr). 2016 Feb;38(1):16. doi: 10.1007/s11357-016-9871-8. Epub 2016 Jan 28.

Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice

Machado V, Zöller T, Attaai A, Spittau B.

Int J Mol Sci. 2016 Jan 26;17(2):151. doi: 10.3390/ijms17020151.

Comparison of Self-report and Performance-Based Balance Measures for Predicting Recurrent Falls in People With Parkinson Disease: Cohort Study

Almeida LR, Valenca GT, Negreiros NN, Pinto EB, Oliveira-Filho J.

Phys Ther. 2016 Jul;96(7):1074-84. doi: 10.2522/ptj.20150168. Epub 2016 Jan 28.

Development of stem cell-based therapies for Parkinson's disease

Zhu B, Caldwell M, Song B.

Int J Neurosci. 2016 Nov;126(11):955-62. doi: 10.3109/00207454.2016.1148034. Epub 2016 Feb 28.

Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?

Videnovic A, Willis GL.

Mov Disord. 2016 Mar;31(3):260-9. doi: 10.1002/mds.26509. Epub 2016 Jan 30.

Abdominal massage for the alleviation of symptoms of constipation in people with Parkinson's: a randomised controlled pilot study

McClurg D, Hagen S, Jamieson K, Dickinson L, Paul L, Cunnington A.

Age Ageing. 2016 Mar;45(2):299-303. doi: 10.1093/ageing/afw005. Epub 2016 Jan 29.

Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders

Nguyen L, Thomas KL, Lucke-Wold BP, Cavendish JZ, Crowe MS, Matsumoto RR.

Pharmacol Ther. 2016 Mar;159:1-22. doi: 10.1016/j.pharmthera.2016.01.016. Epub 2016 Jan 28.

Clinical Approach to Progressive Supranuclear Palsy

Ling H.

J Mov Disord. 2016 Jan;9(1):3-13. doi: 10.14802/jmd.15060. Epub 2016 Jan 25.

Mechanism of Anti-α-Synuclein Immunotherapy

Lee JS, Lee SJ.

J Mov Disord. 2016 Jan;9(1):14-9. doi: 10.14802/jmd.15059. Epub 2016 Jan 25.

Kurtosis imaging reveals microstructural changes of late-stage α-synuclein accumulation in a mouse model of Parkinson's disease

Williams S.

J Neurochem. 2016 Mar;136(6):1117-1118. doi: 10.1111/jnc.13522. Epub 2016 Feb 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias